
Oncolytic Virus Immunotherapy Market
Oncolytic Virus Immunotherapy Market - Global Industry Assessment & Forecast
Segments Covered
By Product Type Herpes Simplex Virus, Adenovirus, Vaccinia Virus, Vesicular Stomatitis Virus, Other Product Types
By Application Melanoma, Prostate Cancer, Ovarian Cancer, Lung Cancer, Breast Cancer, Other Applications
By End User Hospitals, Specialty Clinics, Cancer Research Institutes
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
![]() |
2022 |
![]() |
2023 - 2030 |
![]() |
2017 - 2021 |
![]() |
USD 100 Million |
![]() |
USD 615.39 Million |
![]() |
25.5% |
![]() |
Asia Pacific |
![]() |
North America |
Customization Offered
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst
-
Executive Dashboard
- Strategic Imperatives
-
Premium Insights
- Top 3 Trends to Watch
- Demand and Supply Trends
- Top 3 Strategies Followed by Major Players
- Top 3 Predictions by Vantage Market Research
- Top Investment Pockets
- Insights from Primary Respondents
-
Global Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- Global Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
Global Oncolytic Virus Immunotherapy Market - by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
Global Oncolytic Virus Immunotherapy Market - by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
Global Oncolytic Virus Immunotherapy Market - by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
Global Oncolytic Virus Immunotherapy Market - by region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Market comparative analysis
-
North America Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- North America Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
North America Oncolytic Virus Immunotherapy Market, by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
North America Oncolytic Virus Immunotherapy Market, by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
North America Oncolytic Virus Immunotherapy Market, by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
North America Oncolytic Virus Immunotherapy Market, by Country
- U.S.
- U.S. Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- U.S. Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- U.S. Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- U.S. Oncolytic Virus Immunotherapy Market, By Product Type
- Canada
- Canada Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Canada Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Canada Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Canada Oncolytic Virus Immunotherapy Market, By Product Type
- Mexico
- Mexico Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Mexico Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Mexico Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Mexico Oncolytic Virus Immunotherapy Market, By Product Type
- U.S.
-
Europe Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- Europe Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
Europe Oncolytic Virus Immunotherapy Market, by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
Europe Oncolytic Virus Immunotherapy Market, by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
Europe Oncolytic Virus Immunotherapy Market, by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
Europe Oncolytic Virus Immunotherapy Market, by Country
- Germany
- Germany Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Germany Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Germany Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Germany Oncolytic Virus Immunotherapy Market, By Product Type
- UK
- UK Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- UK Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- UK Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- UK Market, By Product Type
- France
- France Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- France Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- France Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- France Oncolytic Virus Immunotherapy Market, By Product Type
- Spain
- Spain Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Spain Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Spain Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Spain Oncolytic Virus Immunotherapy Market, By Product Type
- Italy
- Italy Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Italy Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Italy Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Italy Oncolytic Virus Immunotherapy Market, By Product Type
- BENELUX
- BENELUX Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- BENELUX Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- BENELUX Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- BENELUX Oncolytic Virus Immunotherapy Market, By Product Type
- Rest of Europe
- Rest Of Europe Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Rest Of Europe Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Rest Of Europe Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Rest Of Europe Oncolytic Virus Immunotherapy Market, By Product Type
- Germany
-
Asia Pacific Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- Asia Pacific Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
Asia Pacific Oncolytic Virus Immunotherapy Market, by Country
- China
- China Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- China Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- China Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- China Oncolytic Virus Immunotherapy Market, By Product Type
- Japan
- Japan Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Japan Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Japan Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Japan Oncolytic Virus Immunotherapy Market, By Product Type
- India
- India Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- India Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- India Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- India Oncolytic Virus Immunotherapy Market, By Product Type
- South Korea
- South Korea Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- South Korea Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- South Korea Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- South Korea Oncolytic Virus Immunotherapy Market, By Product Type
- South East Asia
- South East Asia Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- South East Asia Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- South East Asia Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- South East Asia Oncolytic Virus Immunotherapy Market, By Product Type
- Rest of Asia Pacific
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Rest of Asia Pacific Oncolytic Virus Immunotherapy Market, By Product Type
- China
-
Latin America Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- Latin America Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
Latin America Oncolytic Virus Immunotherapy Market, by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
Latin America Oncolytic Virus Immunotherapy Market, by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
Latin America Oncolytic Virus Immunotherapy Market, by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
Latin America Oncolytic Virus Immunotherapy Market, by Country
- Brazil
- Brazil Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Brazil Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Brazil Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Brazil Oncolytic Virus Immunotherapy Market, By Product Type
- Argentina
- Argentina Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Argentina Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Argentina Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Argentina Oncolytic Virus Immunotherapy Market, By Product Type
- Rest of Latin America
- Rest of Latin America Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Rest of Latin America Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Rest of Latin America Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Rest of Latin America Oncolytic Virus Immunotherapy Market, By Product Type
- Brazil
-
Middle East & Africa Oncolytic Virus Immunotherapy Market - Segment Analysis
- Overview
- Middle East & Africa Oncolytic Virus Immunotherapy Market, 2016 - 2028 (USD Million)
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
-
Middle East & Africa Oncolytic Virus Immunotherapy Market, by Country
- GCC Countries
- GCC Countries Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- GCC Countries Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- GCC Countries Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- GCC Countries Oncolytic Virus Immunotherapy Market, By Product Type
- South Africa
- South Africa Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- South Africa Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- South Africa Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- South Africa Oncolytic Virus Immunotherapy Market, By Product Type
- Rest of Middle East & Africa
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, By Product Type
- By Herpes Simplex Virus
- By Adenovirus
- By Vaccinia Virus
- By Vesicular Stomatitis Virus
- By Other Product Types
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, By Application
- By Melanoma
- By Prostate Cancer
- By Ovarian Cancer
- By Lung Cancer
- By Breast Cancer
- By Other Applications
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, By End User
- By Hospitals
- By Specialty Clinics
- By Cancer Research Institutes
- Rest of Middle East & Africa Oncolytic Virus Immunotherapy Market, By Product Type
- GCC Countries
-
Key Market Dynamics
- Introduction
- Market Drivers
- Market Restraints
- Market Opportunities
- Porter's Five Forces Analysis
- PEST Analysis
- Regulatory Landscape
- Technology Landscape
- Regional Market Trends
-
COVID 19 Impact Analysis
- Key strategies undertaken by companies to tackle COVID-19
- Short term dynamics
- Long term dynamics
-
Marketing Stratagy Analysis
- Marketing Channel
- Direct Marketing
- Indirect Marketing
- Marketing Channel Development Trends
-
Competative Landscape
- Competition Matrix - 2021
- Company Market Share Analysis - 2021
- Key Company Activities, 2018 - 2021
- Strategic Developments - Heat Map Analysis
- Company Offering Evaluation
- Company Regional Presence Evaluation
-
Company Profiles
- Sorrento Therapeutics Inc. (U.S.)
- Merck & Co. Inc. (U.S.)
- Amgen Inc. (U.S.)
- Shanghai Sunway Biotech Co. Ltd. (China)
- Cold Genesys Inc. (U.S.)
- Oncolytics Biotech Inc. (Canada)
- Transgene Biotek Ltd. (India)
- SillaJen Inc. (South Korea)
- ORYX GmbH & Co. KG (Germany)
- Viralytics Ltd. (Australia)
- Key Primary Respondents - VERBATIM
- Discussion Guide
- Customization Offered
- Annexure
- List of Figures
- List of Tables
- List of Abbreviations
FAQ
Frequently Asked Question
What is the global demand for Oncolytic Virus Immunotherapy in terms of revenue?
-
The global Oncolytic Virus Immunotherapy valued at USD 100 Million in 2022 and is expected to reach USD 615.39 Million in 2030 growing at a CAGR of 25.5%.
Which are the prominent players in the market?
-
The prominent players in the market are Sorrento Therapeutics Inc. (U.S.), Merck & Co. Inc. (U.S.), Amgen Inc. (U.S.), Shanghai Sunway Biotech Co. Ltd. (China), Cold Genesys Inc. (U.S.), Oncolytics Biotech Inc. (Canada), Transgene Biotek Ltd. (India), SillaJen Inc. (South Korea), ORYX GmbH & Co. KG (Germany), Viralytics Ltd. (Australia).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 25.5% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Oncolytic Virus Immunotherapy include
- Rising incidences of cancer and growing cases of Genetic diseases
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Oncolytic Virus Immunotherapy in 2022.